It’s Time to Rethink How You Handle Cloning Out Distractions – Fstoppers

Whether youve worked with Photoshop for years, or are new to the program and want an updated approach to cloning, healing, and editing out distractions and issues, theres been a number of updates that have challenged the old paradigm of editing in these situations. Want to know the new approach you should be using?

When I got started with Photoshop, and had to deal with removing an element of an image, Id reach for either the clone stamp or healing brush tool. Both were fine, but required a good sense of how to rebuild the areas, if you were removing a sizable chunk of the photo. For this next section, when I refer to cloning, you can consider healing and cloning to both run into the same issues, at least to some extent.

Beyond just size, theres a number of complicating factors that can make these tools more difficult to use than necessary. Consider an object against a pattern background, where youll have to pay attention to matching the orientation and periodicity of the pattern itself, rather than just cloning over it with a random sample. Another example is when cloning up against the border of two different objects, especially where theres a defined edge. Working near that edge with a healing brush can result in a blurry mess, instead of a clean replacement.

To work around these challenges, Photoshop has added a number of tools that I dont think get enough attention for this part of the workflow. Furthermore, there are a number of optimizations to how you work with the existing tools that can help address these issues.

The first change Id recommend making is altering how you approach editing out a distraction in the first place. Instead of reaching for a brush of any type or the patch tool, grab the lasso tool. Combined with content aware fill, I find it much easier to make selections quickly, hit my reassigned shortcut for fill (faster than Edit> Fill), and end up with a great looking result for basic adjustments.

I like this better than the brush approach because of how well it leads into making adjustments to the area being fixed. If I need to end up selecting more of a region, like if theres a color cast spilling onto the background, its easy to add to the selection. If Im removing too much, just by holding Alt, I can quickly remove something from the selection. In the very rare cases where Photoshop isnt automatically selecting a good patch to fill with, its easy to jump into the dedicated Content Aware Fill dialog, as your selection is already set up.

This approach isnt just good for its versatility, but also because it is very low effort. Draw a sloppy circle around what you want gone and it vanishes. Content Aware Fill seems to do a remarkable job of leaving things alone that dont need to be removed, even if its in the active selection, unlike when you draw outside the area with the spot healing brush.

Furthermore, Photoshop offers a ton of options for making an easy, effective selection, making this approach even easier. A great example of this is when working with a panorama. After stitching, you can end up with small gaps around the edges of the frame, where the stitch hasnt resulted in a perfectly rectangular image. To fill these in with a brush-based approach would require a detailed examination of the edges of the frame and painstaking work to brush in only the necessary regions. Instead, by selecting all the content on the layer, inverting the selection, and expanding it by a few pixels, you can quickly fill all these gaps automatically. Ive even loaded that process into an action, taking what would have been minutes of work into about 5 seconds and 2 clicks.

To sum it up, when working with an easy, or even intermediate issue, Ive left the myriad healing and cloning brushes in the toolbar, instead relying on sloppy selections and Content Aware fill via both the fill menu and dedicated dialog. Its saved a lot of effort, and can easily be stepped up to deal with more difficult cases.

Unfortunately, Content Awares AI isnt at Skynet levels just yet, For some areas, its still necessary to go in and manually clone out the region. This is most noticeable in the cases I mentioned earlier in the article, with regular patterns and some literal edge cases. Here, however, I still dont leave the selection tools behind.

Making a selection before working with cloning tools can be one of the best ways to refine your approach. One of the easiest examples of this is when working with something that comes up to an edge of another object. In these three shots, you can see the initial issue, the selection, and the finished product. By going in with just the regular clone stamp, you can build in some margin around that white pillar, while still keeping a very clean edge on the object. Once thats done, you can then use any tool, like the healing brush, to go in and finish the job, as well as refine the transition.

Trying to mirror that rounded edge with a single brush stroke is way more difficult than it needs to be. Setting up the selection ahead of time functions a bit like the bumper guards in bowling, where even a mistake doesnt ruin your attempt.

Setting up this perimeteralso leads into my next bit of advice, which is dont be afraid of the clone stamp. While the initial strokes can look worse than using the healing brush or spot healing brush, I find that for larger areas, you can never get the healing brush to look just right without first removing the offending object via another method. Healing over a large area can just result in a smudgy mess, often with color artifacts from the removed object. Instead, give a couple swipes of the clone stamp to at least get the area into a more neutral starting position, then refine with the healing tools if necessary.

One last thing to remember is the clone source panel. If youre working with an offset pattern, or dont have a great 1:1 match for cloning, you can use the clone source panel to expand your options. In the panel, you can adjust the rotation of your clone source to better match your subject, increase or decrease the scaling ratio, or even mirror it. By playing around with these settings, you can get a far more convincing blendor even create a usable source out of an otherwise dissimilar area.

None of these features are that new, with content aware fill being around for years already, for example. Instead, the iterative improvements of content aware fill, combined with some new techniques Ive integrated into my workflow, have led me to realize that I hardly even touch the old standards of cloning work anymore. As content aware fill continues to improve, Ive had to do less and less manual refinement. Id suggest you see how it fits into your workflow, as well as understand the cases where it isnt going to be useful, and how to compensate it might just save you quite a bit of time in your next edit!

Originally posted here:

It's Time to Rethink How You Handle Cloning Out Distractions - Fstoppers

Global Synthetic Biolog Market 2020 COVID-19 Updated Analysis By Product (Xeno-nucleic Acids (XNA), Oligonucleotides, Chassis Organisms, Enzymes,…

Synthetic Biolog Industry Overview Competitive Analysis, Regional and Global Analysis, Segment Analysis, Market Forecasts 2026

TheSynthetic Biolog marketreport begins with the market overview/market definition and the market scope. This helps in understanding what exactly is the report study dealing with. The next section includes the target audience of the Synthetic Biolog market. It is very important for the clients to understand what type of users or what kind of consumers deal with Synthetic Biolog market in order to determine their focus goals.

Request Free Sample Copy of Synthetic Biolog Market Research Report@http://www.marketresearchstore.com/report/global-synthetic-biolog-market-report-2018-industry-research-268155#RequestSample

In the last section, the Synthetic Biolog market report incorporates detailed information on the demand & supply chain analysis, import and export, industry size, sales volume, market shares, as well as value analysis of all the industry players operating in the Synthetic Biolog market. Some of the major market players that are included areIntrexon Corporation (U.S.), Synthetic Genomics, Inc. (California), Novozymes (Denmark), Royal DSM (Netherlands), New England Biolabs, Inc. (NEB) (U.S.), Integrated DNA Technologies (IDT) (U.S.), Amyris, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), DuPont (U.S.), GenScript USA Inc. (U.S.. Each market player is profiles in detail within the report by the research analysts.

In the next section, the Synthetic Biolog market report includes the research tools and methodologies that were incorporated while studying the Synthetic Biolog market. For instance, Porters Five Force analysis, SWOT analysis, PESTLE analysis, top-down or the bottom-up approach that was used for market data analysis. It also includes details about the primary research and the secondary research that were conducted by the research analysts.

Read Detailed Index of full Research Study at::http://www.marketresearchstore.com/report/global-synthetic-biolog-market-report-2018-industry-research-268155

The next major section of the Synthetic Biolog market study includes the market segmentation. To understand any market with ease the market is segregated into segments, such as its product type, application, technology, end-use industry. By dividing the market into small components helps in understanding the market with more clarity. The market segments of the Synthetic Biolog market includes{Xeno-nucleic Acids (XNA), Oligonucleotides, Chassis Organisms, Enzymes, Cloning and Assembly kits}; {Environmental Application, Medical Application, Industrial Application}. The data that is provided within the study is both quantitative and qualitative. Data is represented with the help of tables and figures that include graphical representation of the numbers in the form of histograms, bar graphs, pie charts, etc.

Another major segment of the Synthetic Biolog market is its geographical presence on the global platform. The major regions that have been considered include Asia Pacific, Europe, Latin America, North America, and the Middle East and Africa. The Synthetic Biolog market study is not restricted to regional level but also includes country-wise data.

If Any Inquiry of Synthetic Biolog Report:http://www.marketresearchstore.com/report/268155#InquiryForBuying

Major Advantages for Synthetic Biolog Market:

Well-organized description of the international Synthetic Biolog market along with the ongoing inclinations and future considerations to reveal the upcoming investment areas. The all-inclusive market feasibility is examined to figure out the profit-making trends to obtain the most powerful foothold in the Synthetic Biolog industry. The Synthetic Biolog market report covers data which reveal major drivers, constraints, and openings with extensive impact analysis. The current market is quantitatively reviewed from 2019 to 2028 to pinpoint the monetary competency of the global Synthetic Biolog market. Last but not least, PORTERS Five Forces Analysis shows the effectiveness of the customers and providers from a global perspective.

Excerpt from:

Global Synthetic Biolog Market 2020 COVID-19 Updated Analysis By Product (Xeno-nucleic Acids (XNA), Oligonucleotides, Chassis Organisms, Enzymes,...

Facebook bans content promoting ‘conversion therapy’ – Macau Business

Facebook on Friday said it is banning content that promotes conversion therapy, which is based on the unfounded notion that gays can change their sexual orientation through psychological or spiritual intervention.

Facebook and its image-centric social network Instagram are updating policies to require removal of content that directly promotes conversion therapy when such posts are flagged by users, according to the California-based internet giant.

The move is an extension of an existing ban on ads that promote the tactic, which medical experts consider ineffective and often harmful.

We dont allow attacks against people based on sexual orientation or gender identity and are updating our policies to ban the promotion of conversion therapy services, a Facebook spokesperson said in response to an AFP inquiry.

We are always reviewing our policies and will continue to consult with experts and people with personal experiences to inform our approach.

Conversion therapy interventions include electric shock, food deprivation and chemically-induced nausea, the American Medical Association has said in a report.

Empirical evidence demonstrates that sexuality and gender identities in people vary naturally, with the idea of conversion a misconception, the report said.

Such sexual orientation change efforts not only dont work, they may cause significant distress, the AMA said, citing a study showing they caused depression, anxiety, alienation, and other ill effects.

Another study cited by the AMA found that nearly 30 percent of people who underwent conversion therapy reported suicide attempts.

Read more from the original source:

Facebook bans content promoting 'conversion therapy' - Macau Business

What is alternate medicine and what are the different forms of it? – The Bridge

Most of the world has been in lockdown with the exception of a few places and people across the globe are getting impatient waiting for the vaccine to the pandemic which has led to work from home and has made precautionary measures as the new normal. A lot have switched to alternative forms of healing which have existed for a long time now but have gained recent traction due to diminishing faith in modern medicine or for personal reasons.

Aromatherapy

Aromatherapy is a form of alternative holistic healing that has existed for thousands of years. It works via essential oil which is natural extracts. They are then used in the form of resins, oils and balms. It is usually applied on the skin and through smell (as the first part of the name suggests). Bathing salts, inhalers, diffusers are some products that are generally associated with aromatherapy healing. It is known to alleviate the pain that is often caused due to stress, anxiety and improve sleep quality, digestion and immunity. Though one should be wary as there are unproven claims such as aromatherapy treating Parkinsons disease and Alzheimers that havent been backed by research studies. It, however, can treat insomnia, anxiety and fatigue among some other illnesses.

Massage Therapy (Source: EVOLV Wellness)

Ayurveda

Ayurveda is among one of the many gifts India has given to the world has existed for thousands of years. It has been mentioned in various western medicine studies and also had a few clinical trials conducted to document the many benefits that have been claimed by people. It ranks very high in the field of alternative medicine with various health benefits that have been claimed such as increased immunity due to including consumption of herbs like turmeric which reduce inflammation and allows the body to fight foreign bacteria better. However, it is also not medically recognized and one should avoid including some forms of as it may contain lead or mercury. Despite some negative points, Ayurveda has shown to improve overall health and get rid of bad toxins from the body.

Massage Therapy

Massage Therapy is one of the few forms of healing that focus on the physical self. It comprises of massages that can be associated with clinical or sports concerns or stress in general. A clinical context would be to massage stiff areas, stressed or often have muscle spasms and this form of therapy would heal the pain. Massage therapy is also prevalent among top-level athletes who require the body to function at optimal levels to compete in various sports. Massages can help reduce the muscle soreness after a difficult workout which can help in better performance the day after. NCCIH states that there are little benefits when it comes to massage therapy helping cancer patients or people suffering from aids. Risks arent high when it comes to this form of therapy compared to many other forms of alternative medicine however one can suffer from a blood clot or fracture if the masseur/masseuse isnt careful.

These are some of the many forms of alternative medicine available today. Though each one of them comes with their own risks, some also have been shown to benefit overall health and treatment of diseases. It is important that one must do full research on the health benefits, side effects, legality among other factors and consult multiple opinions before choosing to adopt a form of alternative medicine.

See the original post here:

What is alternate medicine and what are the different forms of it? - The Bridge

Complementary and Alternative Medicine Market 2020:Key market Insights, Drivers and Restraints, Opportunities and Challenges, Sales and Revenue and…

Complementary and Alternative Medicine Market Research Report

Los Angeles, United States, July 8th, 2020, The report on the global Complementary and Alternative Medicine market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that players could improve their sales and growth in the Global Complementary and Alternative Medicine Market. It offers a detailed analysis of the competition and leading companies of the global Complementary and Alternative Medicine market. Here, it concentrates on the recent developments, sales, market value, production, gross margin, and other important factors of the business of top players operating in the global Complementary and Alternative Medicine market.

With deep quantitative and qualitative analysis, the report provides encyclopedic and accurate research study on important aspects of the global Complementary and Alternative Medicine market. It brings to light key factors affecting the growth of different segments and regions in the global Complementary and Alternative Medicine market. It also offers SWOT, Porters Five Forces, and PESTLE analysis to thoroughly examine the global Complementary and Alternative Medicine market. It gives a detailed study on manufacturing cost, upstream and downstream buyers, distributors, marketing strategy, and marketing channel development trends of the global Complementary and Alternative Medicine market. Furthermore, it provides strategic bits of advice and recommendations for players to ensure success in the global Complementary and Alternative Medicine market.

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1698359/covid-19-impact-on-global-complementary-and-alternative-medicine-market

Some of the Important Key player operating in this Report are: , Columbia Nutritional, Herb Pharm, Herbal Hills, Helio USA, Deepure Plus, Nordic Naturals, Pure encapsulations, Iyengar Yoga Institute, John Schumachers Unity Woods Yoga Center, Yoga Tree, The Healing Company, Quantum Touch Complementary and Alternative Medicine

Segmental Analysis

The report has classified the global Complementary and Alternative Medicine industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Complementary and Alternative Medicine manufacturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Railway Signaling System industry.

Complementary and Alternative Medicine Segmentation by Product

, Botanicals, Acupuncture, Mind, Body, and Yoga, Magnetic Intervention Complementary and Alternative Medicine

Complementary and Alternative Medicine Segmentation by Application

Direct Contact, E-training, Distance Correspondence

Regions and Countries

The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Key Questions Answered

What is the size and CAGR of the global Complementary and Alternative Medicine market?

Which are the leading segments of the global Complementary and Alternative Medicine market?

What are the key driving factors of the most profitable regional market?

What is the nature of competition in the global Complementary and Alternative Medicine market?

How will the global Complementary and Alternative Medicine market advance in the coming years?

What are the main strategies adopted in the global Complementary and Alternative Medicine market?

Enquiry for Customization in the Report @https://www.qyresearch.com/customize-request/form/1698359/covid-19-impact-on-global-complementary-and-alternative-medicine-market

Table of Contents

1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Players Covered: Ranking by Complementary and Alternative Medicine Revenue1.4 Market Analysis by Type1.4.1 Global Complementary and Alternative Medicine Market Size Growth Rate by Type: 2020 VS 20261.4.2 Botanicals1.4.3 Acupuncture1.4.4 Mind, Body, and Yoga1.4.5 Magnetic Intervention1.5 Market by Application1.5.1 Global Complementary and Alternative Medicine Market Share by Application: 2020 VS 20261.5.2 Direct Contact1.5.3 E-training1.5.4 Distance Correspondence1.6 Coronavirus Disease 2019 (Covid-19): Complementary and Alternative Medicine Industry Impact1.6.1 How the Covid-19 is Affecting the Complementary and Alternative Medicine Industry

1.6.1.1 Complementary and Alternative Medicine Business Impact Assessment Covid-19

1.6.1.2 Supply Chain Challenges

1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products1.6.2 Market Trends and Complementary and Alternative Medicine Potential Opportunities in the COVID-19 Landscape1.6.3 Measures / Proposal against Covid-19

1.6.3.1 Government Measures to Combat Covid-19 Impact

1.6.3.2 Proposal for Complementary and Alternative Medicine Players to Combat Covid-19 Impact1.7 Study Objectives1.8 Years Considered 2 Global Growth Trends by Regions2.1 Complementary and Alternative Medicine Market Perspective (2015-2026)2.2 Complementary and Alternative Medicine Growth Trends by Regions2.2.1 Complementary and Alternative Medicine Market Size by Regions: 2015 VS 2020 VS 20262.2.2 Complementary and Alternative Medicine Historic Market Share by Regions (2015-2020)2.2.3 Complementary and Alternative Medicine Forecasted Market Size by Regions (2021-2026)2.3 Industry Trends and Growth Strategy2.3.1 Market Top Trends2.3.2 Market Drivers2.3.3 Market Challenges2.3.4 Porters Five Forces Analysis2.3.5 Complementary and Alternative Medicine Market Growth Strategy2.3.6 Primary Interviews with Key Complementary and Alternative Medicine Players (Opinion Leaders) 3 Competition Landscape by Key Players3.1 Global Top Complementary and Alternative Medicine Players by Market Size3.1.1 Global Top Complementary and Alternative Medicine Players by Revenue (2015-2020)3.1.2 Global Complementary and Alternative Medicine Revenue Market Share by Players (2015-2020)3.1.3 Global Complementary and Alternative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.2 Global Complementary and Alternative Medicine Market Concentration Ratio3.2.1 Global Complementary and Alternative Medicine Market Concentration Ratio (CR5 and HHI)3.2.2 Global Top 10 and Top 5 Companies by Complementary and Alternative Medicine Revenue in 20193.3 Complementary and Alternative Medicine Key Players Head office and Area Served3.4 Key Players Complementary and Alternative Medicine Product Solution and Service3.5 Date of Enter into Complementary and Alternative Medicine Market3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026)4.1 Global Complementary and Alternative Medicine Historic Market Size by Type (2015-2020)4.2 Global Complementary and Alternative Medicine Forecasted Market Size by Type (2021-2026) 5 Complementary and Alternative Medicine Breakdown Data by Application (2015-2026)5.1 Global Complementary and Alternative Medicine Market Size by Application (2015-2020)5.2 Global Complementary and Alternative Medicine Forecasted Market Size by Application (2021-2026) 6 North America6.1 North America Complementary and Alternative Medicine Market Size (2015-2020)6.2 Complementary and Alternative Medicine Key Players in North America (2019-2020)6.3 North America Complementary and Alternative Medicine Market Size by Type (2015-2020)6.4 North America Complementary and Alternative Medicine Market Size by Application (2015-2020) 7 Europe7.1 Europe Complementary and Alternative Medicine Market Size (2015-2020)7.2 Complementary and Alternative Medicine Key Players in Europe (2019-2020)7.3 Europe Complementary and Alternative Medicine Market Size by Type (2015-2020)7.4 Europe Complementary and Alternative Medicine Market Size by Application (2015-2020) 8 China8.1 China Complementary and Alternative Medicine Market Size (2015-2020)8.2 Complementary and Alternative Medicine Key Players in China (2019-2020)8.3 China Complementary and Alternative Medicine Market Size by Type (2015-2020)8.4 China Complementary and Alternative Medicine Market Size by Application (2015-2020) 9 Japan9.1 Japan Complementary and Alternative Medicine Market Size (2015-2020)9.2 Complementary and Alternative Medicine Key Players in Japan (2019-2020)9.3 Japan Complementary and Alternative Medicine Market Size by Type (2015-2020)9.4 Japan Complementary and Alternative Medicine Market Size by Application (2015-2020) 10 Southeast Asia10.1 Southeast Asia Complementary and Alternative Medicine Market Size (2015-2020)10.2 Complementary and Alternative Medicine Key Players in Southeast Asia (2019-2020)10.3 Southeast Asia Complementary and Alternative Medicine Market Size by Type (2015-2020)10.4 Southeast Asia Complementary and Alternative Medicine Market Size by Application (2015-2020) 11 India11.1 India Complementary and Alternative Medicine Market Size (2015-2020)11.2 Complementary and Alternative Medicine Key Players in India (2019-2020)11.3 India Complementary and Alternative Medicine Market Size by Type (2015-2020)11.4 India Complementary and Alternative Medicine Market Size by Application (2015-2020) 12 Central & South America12.1 Central & South America Complementary and Alternative Medicine Market Size (2015-2020)12.2 Complementary and Alternative Medicine Key Players in Central & South America (2019-2020)12.3 Central & South America Complementary and Alternative Medicine Market Size by Type (2015-2020)12.4 Central & South America Complementary and Alternative Medicine Market Size by Application (2015-2020) 13 Key Players Profiles13.1 Columbia Nutritional13.1.1 Columbia Nutritional Company Details13.1.2 Columbia Nutritional Business Overview and Its Total Revenue13.1.3 Columbia Nutritional Complementary and Alternative Medicine Introduction13.1.4 Columbia Nutritional Revenue in Complementary and Alternative Medicine Business (2015-2020))13.1.5 Columbia Nutritional Recent Development13.2 Herb Pharm13.2.1 Herb Pharm Company Details13.2.2 Herb Pharm Business Overview and Its Total Revenue13.2.3 Herb Pharm Complementary and Alternative Medicine Introduction13.2.4 Herb Pharm Revenue in Complementary and Alternative Medicine Business (2015-2020)13.2.5 Herb Pharm Recent Development13.3 Herbal Hills13.3.1 Herbal Hills Company Details13.3.2 Herbal Hills Business Overview and Its Total Revenue13.3.3 Herbal Hills Complementary and Alternative Medicine Introduction13.3.4 Herbal Hills Revenue in Complementary and Alternative Medicine Business (2015-2020)13.3.5 Herbal Hills Recent Development13.4 Helio USA13.4.1 Helio USA Company Details13.4.2 Helio USA Business Overview and Its Total Revenue13.4.3 Helio USA Complementary and Alternative Medicine Introduction13.4.4 Helio USA Revenue in Complementary and Alternative Medicine Business (2015-2020)13.4.5 Helio USA Recent Development13.5 Deepure Plus13.5.1 Deepure Plus Company Details13.5.2 Deepure Plus Business Overview and Its Total Revenue13.5.3 Deepure Plus Complementary and Alternative Medicine Introduction13.5.4 Deepure Plus Revenue in Complementary and Alternative Medicine Business (2015-2020)13.5.5 Deepure Plus Recent Development13.6 Nordic Naturals13.6.1 Nordic Naturals Company Details13.6.2 Nordic Naturals Business Overview and Its Total Revenue13.6.3 Nordic Naturals Complementary and Alternative Medicine Introduction13.6.4 Nordic Naturals Revenue in Complementary and Alternative Medicine Business (2015-2020)13.6.5 Nordic Naturals Recent Development13.7 Pure encapsulations13.7.1 Pure encapsulations Company Details13.7.2 Pure encapsulations Business Overview and Its Total Revenue13.7.3 Pure encapsulations Complementary and Alternative Medicine Introduction13.7.4 Pure encapsulations Revenue in Complementary and Alternative Medicine Business (2015-2020)13.7.5 Pure encapsulations Recent Development13.8 Iyengar Yoga Institute13.8.1 Iyengar Yoga Institute Company Details13.8.2 Iyengar Yoga Institute Business Overview and Its Total Revenue13.8.3 Iyengar Yoga Institute Complementary and Alternative Medicine Introduction13.8.4 Iyengar Yoga Institute Revenue in Complementary and Alternative Medicine Business (2015-2020)13.8.5 Iyengar Yoga Institute Recent Development13.9 John Schumachers Unity Woods Yoga Center13.9.1 John Schumachers Unity Woods Yoga Center Company Details13.9.2 John Schumachers Unity Woods Yoga Center Business Overview and Its Total Revenue13.9.3 John Schumachers Unity Woods Yoga Center Complementary and Alternative Medicine Introduction13.9.4 John Schumachers Unity Woods Yoga Center Revenue in Complementary and Alternative Medicine Business (2015-2020)13.9.5 John Schumachers Unity Woods Yoga Center Recent Development13.10 Yoga Tree13.10.1 Yoga Tree Company Details13.10.2 Yoga Tree Business Overview and Its Total Revenue13.10.3 Yoga Tree Complementary and Alternative Medicine Introduction13.10.4 Yoga Tree Revenue in Complementary and Alternative Medicine Business (2015-2020)13.10.5 Yoga Tree Recent Development13.11 The Healing Company10.11.1 The Healing Company Company Details10.11.2 The Healing Company Business Overview and Its Total Revenue10.11.3 The Healing Company Complementary and Alternative Medicine Introduction10.11.4 The Healing Company Revenue in Complementary and Alternative Medicine Business (2015-2020)10.11.5 The Healing Company Recent Development13.12 Quantum Touch10.12.1 Quantum Touch Company Details10.12.2 Quantum Touch Business Overview and Its Total Revenue10.12.3 Quantum Touch Complementary and Alternative Medicine Introduction10.12.4 Quantum Touch Revenue in Complementary and Alternative Medicine Business (2015-2020)10.12.5 Quantum Touch Recent Development 14 Analysts Viewpoints/Conclusions 15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.2 Data Source15.2 Disclaimer15.3 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.

Read more from the original source:

Complementary and Alternative Medicine Market 2020:Key market Insights, Drivers and Restraints, Opportunities and Challenges, Sales and Revenue and...

Having an African Island all to Yourself – iAfrica.com

Share with your network!

Nature rules on this conservation-focused island in the Seychelles, a veritable Garden of Eden thats home to more than 3,000 Aldabra tortoises, over 100 species of seabirds, and numerous rare and endemic creatures. On the faraway islands off Mozambique, its entirely possible to go off-the-grid, especially at Anantara Bazaruto Island Resort, a colossal private island paradise boasting a palm-laced coastline, jewel-toned waters, towering interior sand dunes, untouched coral reefs, and underwater deserts. The sparkling white sands and impossibly turquoise waters of the Indian Ocean envelop the 10 rustic chic villas of this petite island resort off the northern coast of Zanzibar. Thanks to a distinctive open-air design with limited wall space and glassless windows, the sights and sounds of the beach are always present. Thanks to private island resorts like the Four Seasons Resort Seychelles at Desroches Island, the Indian Ocean has become a popular tack-on after a safari in Africas wildlife-rich plains.

SOURCE:CN TRAVELER

Share with your network!

Continue reading here:

Having an African Island all to Yourself - iAfrica.com

The Maldives Is Reopening This Month to Cure Your Lockdown Malaise – Yahoo Lifestyle

Click here to read the full article.

For the past four months, overseas travel has felt like a far-off fantasy thanks to a certain global pandemic. But, finally, theres light at the end of the quarantine tunnelat least for one of our favorite travel destinations. The Maldives is reopening in a few days.

The tropical island nation, which comprises nearly 1,200 islands in the Indian Ocean, is secluded by nature and well-suited to social distancing. To date, there are roughly 150 eye-catching resorts scattered across the archipelago, most of which occupy entire private islands and call for a minimal amount of human interaction.

More from Robb Report

Since the remote destination relies heavily on tourism, its eager to get back into the swing of things. As of July 15, international travelers, including US citizens, will be allowed to stay only on resort islands or boats (just in case you have a superyacht handy). Come August 1, guest houses and hotels on inhabited islands will also be allowed to reopen.

So, where exactly can you stay? By the end of July, the Maldives Ministry of Tourism expects that a total of 40 resorts will be up and running. According to a list from the ministry, the Four Seasons Resort Maldives at Landaa Giraavaru and Soneva Fushi are already welcoming guests, while the One & Only Reethi Rah and Milaidhoo Island while open July 24 and August 1, respectively. Roughly 50 of the remaining resorts plan to open around October 1, while the rest will likely wait until peak seasonDecember to Marchwhen the tropical weather is at its best.

The Maldives has been working toward reopening for weeks and has implemented all recommended cleanliness and hygiene protocols to ensure guests stay safe. The country has also made a concerted effort to build out resources to treat Covid-19, according to Bloomberg.

Story continues

Entering the Maldives seems to be relatively straightforward, too. Tourists are not required to pay any additional fees or prove theyre virus-free prior to entry, according to an announcement from the Maldives Marketing & PR Corporation. And guests without Covid-19 symptoms will not be subject to quarantine measures on arrival. However, any guest who shows symptoms will have to pay for a test. As you might expect, those who may have been exposed to the virus are advised not to travel to the Maldives.

Of course, youll need to be cautious while traveling to and from the country. And, upon return, the US Centers for Disease Control and Prevention recommends any international travelers self-quarantine for 14 days.

In short, this trip will require some planning. But after months stuck at home, itll be so worth it.

Best of Robb Report

Sign up for Robb Report's Newsletter. For the latest news, follow us on Facebook, Twitter, and Instagram.

More:

The Maldives Is Reopening This Month to Cure Your Lockdown Malaise - Yahoo Lifestyle

The Maldives Is Reopening and, Yes, Even Americans Are Allowed – BNN

(Bloomberg) -- Heres some good news for those frustrated by the lack of travel options in the Covid-19 era: The Maldives isreopening to international visitors on July 15.

And, yes, that includes U.S. citizens.

Thepicturesque chain of almost 1,200 islands in the Indian Ocean has a remote location that lends itself naturally to social distancing, with luxury accommodations focused on private overwater bungalows and much of the activity outdoors as wellall fortunate factors forthe economy of the 400,000-person country thatsheavily dependent on tourism.

International visitors will be allowed only on resort islands and live-aboard boats as of July 15; on Aug. 1,guest houses and hotels on inhabited islands will be allowed to reopen. Of course, that comes with the big caveat that you still have to get thereand then get back.

The U.S. Centers for Disease Control and Prevention notes that anyone traveling on an airplane is at increased risk of contracting Covid-19 because ofclose contact with others at airports and on flights themselves. The CDC alsoadvises anyone returning to America from another country to stay home for 14 days,avoid contact with others, and monitor for symptoms such asa fever or cough. Conversely, theres the increasedrisk of bringing the virus abroad, as cases trend upwardin the U.S.

In other words: Visiting is no small affair. Nor is it cheap. Because almost every resort in the Maldives is its own private island, many luxury hotels charge upwards of$1,500 a night. (Spending twice that muchis hardly unheard of.) And thats before seaplane or speed boat transfers, which can run a hundreds of dollars round trip.

Smoothing the Process

Still, the Maldives is trying to make it relatively easy, at least on its end.

Tourists are not required to pay an additional fee, produce a certificate ortest result indicative of negative status for Covid-19 prior to entry into Maldives. For tourists without symptoms, there is no requirement for quarantine either, according to anannouncement fromthe Maldives Marketing & PR Corp.

Any tourist who does show Covid-19 symptoms will have to pay for a test, the statement cautioned, adding that people with visible symptoms or those with a history of contact with a confirmed Covid-19 case are advised not to travel to Maldives.

The Maldiveshas been working toward the reopening for weeks. The impact of the pandemic on the tourism sector has ranked up there with the 2004 tsunami and the global financial crisis.

Those who do venture to the archipelago will have some choice. By the end of the month,more than 40resorts out of a total of about 150 properties are expected to be operational, according to the Maldives Ministry of Tourism.TheFour Seasons Resort Maldives at Landaa Giraavaru andSoneva Fushiare already open, and the One & Only Reethi Rahwill open on July 24,and Milaidhoo Islandis slated for an Aug. 1 opening,a list from the ministry showed.

Many resorts are waiting a bit longer, thoughand peak season is from around December to March, anyway. Thats when skies are clearest and tropical temperatures fall to more moderate levels.Almost 50 of the resorts on the countrys list are planning to open around Oct. 1. ComoMaalifushi says it willget going again in mid-November.

Safety Protocols

The islandsresorts and accommodations are taking all recommended precautions, a Maldives spokesperson says, and properties have implemented new cleanliness and hygiene protocols to ensure that guests will be safe.

Some of those protocols fall on the more basic side. TheFour Seasons Resort Maldives at Landaa Giraavaru says it has an arrival procedure that involves a temperature screening and questions about recent travel history.

At theAngsanaVelavaru Maldives resort, all public areas and back-of-house areas are sanitized on an hourly basis, and rooms are deep-cleaned and disinfected with virus-specific protocols, the website says. Temperature checks aremandatory at the spa.

Soneva is taking a stricter approach at its two Maldives resorts, Soneva Jani and SonevaFushi. Sanitizing luggage before passengers even arrive, requiring a real-time PCR Covid-19 test upon arrival (it has invested in a Roche Diagnostics Corp. testing machine), and taking temperatures every day are all part of the process now, according to the companys website. Theresanother Covid-19 test on the fifth day of the stay. Soneva says its hosts, or staff, are tested every five days, and all materials and produce that are comingonto theislands will undergocleaning and sanitation procedures first.

Although this could be considered as being slightly excessive or overcautious, both Soneva Fushi and Soneva Jani are One Island, One Resort; it is our goal to make our private island homes Covid-19 free environments, so that all of our guests can truly relax and engage with our Hosts and fellow travelers and not feel any concern about a risk of infection, the site declares.

If you come up positive, the resorts will still take care of you, with attention from a medical team as you isolate in your villa, and Soneva waiving the daily room rate for the next 14 days. (The value of that stay, in one of Soneva Janis currently-discounted entry-level rooms: $37,723.)

If any guest needsto be hospitalized, the Maldives has built up sufficient hospital and medical capacity to treat Covid-19 effectively, the website says, noting thatthe hospital on aneighboring island, only 10 minutes away by speedboat, has a new ICU unit with 20 beds.

2020 Bloomberg L.P.

See the original post here:

The Maldives Is Reopening and, Yes, Even Americans Are Allowed - BNN

Caymanians urged to have more kids – Cayman Islands Headline News – Cayman News Service

MLA Chris Saunders in the LA, 2 July 2020

(CNS): MLA Chris Saunders (BTW) has said that Caymanians need to make more children to prevent the country from getting into future trouble as a result of a declining birth rate. The opposition MLA made the plea to the country during a debate about amending the Labour Law to make maternity leave provisions for private sector workers equal to those offered in the civil service.

Presenting his private members motion asking government to consider aligning maternity leave between the civil service and the private sector, Saunders explained that the Legislative Assembly had a responsibility to make laws for good government that should be equal and inclusive.

But mothers employed in the private sector, while having the same objectives, responsibilities and challenges as those in the civil service, were not equal and were getting far less maternity leave. While public sector mothers are getting two months paid and one month unpaid leave, those in the private sector get only one month of their time off paid.

He said the inconsistency needed to be corrected for several reasons, not least that government needed to take a leadership role in promoting family life because Caymanians were not replacing themselves. He said Cayman had poor parental rights, which would need to be improved in the long run as the jurisdiction developed. But in the meantime, this alignment would be a step in the right direction.

Despite Caymans strong support for family life, the birth rate is falling, with couples now having less than two children on average.

We need to accept as our population is getting older and we dont have enough people coming behind us to replace ourselves, this is going to be a problem, he said, noting that the fertility rate here is 1.87%, which includes non-Caymanians.

Caymanians were not growing their own indigenous population, which would cause structural problems down the line if this issue was not addressed, Saunders said, as he implied that increasing maternity leave could help.

I know some members have gone out and made multiple children Ive made three so Im above the natural replacement rate, he said, adding that he and his wife had done their job and pointed to other members who had contributed to growing the population.

While he accepted that consideration had to be given to small businesses, he suggested an incremental increase to the maternity benefit to give businesses time to plan. Saunders spoke about the need for more long-term planning in Cayman and to use the census, expected to take place in October, to inform that planning.

Premier Alden McLaughlin said that government was prepared to accept the motion and consider the proposal.

The original motion was amended to increase the time period for government to address the issue to the end of 2021.

See the motion in the CNS Library

See the motion debate on CIGTV below:

More:

Caymanians urged to have more kids - Cayman Islands Headline News - Cayman News Service

COVID-19 Daily Update 7-10-2020 – 5 PM – West Virginia Department of Health and Human Resources

The West Virginia Department of Health andHuman Resources (DHHR) reports as of 5:00 p.m., on July 10,2020, there have been 201,092 total confirmatorylaboratory results received for COVID-19, with 3,983 totalcases and 95 deaths.

Inalignment with updated definitions from the Centers for Disease Control andPrevention, the dashboard includes probable cases which are individuals that havesymptoms and either serologic (antibody) or epidemiologic (e.g., a link to aconfirmed case) evidence of disease, but no confirmatory test.

CASESPER COUNTY (Case confirmed by lab test/Probable case):Barbour(18/0), Berkeley (504/19), Boone (31/0), Braxton (4/0), Brooke (24/1), Cabell(188/6), Calhoun (4/0), Clay (11/0), Fayette (79/0), Gilmer (13/0), Grant(18/1), Greenbrier (69/0), Hampshire (42/0), Hancock (35/3), Hardy (45/1),Harrison (109/0), Jackson (148/0), Jefferson (248/5), Kanawha (381/12), Lewis (19/1),Lincoln (10/0), Logan (35/0), Marion (95/3), Marshall (57/1), Mason (23/0),McDowell (8/0), Mercer (62/0), Mineral (62/2), Mingo (27/2), Monongalia(454/14), Monroe (14/1), Morgan (19/1), Nicholas (15/1), Ohio (138/0),Pendleton (15/1), Pleasants (4/1), Pocahontas (36/1), Preston (79/16), Putnam(78/1), Raleigh (68/3), Randolph (184/2), Ritchie (2/0), Roane (12/0), Summers(2/0), Taylor (22/1), Tucker (6/0), Tyler (9/0), Upshur (22/1), Wayne (121/1),Webster (1/0), Wetzel (30/0), Wirt (6/0), Wood (159/9), Wyoming (7/0).

Ascase surveillance continues at the local health department level, it may revealthat those tested in a certain county may not be a resident of that county, oreven the state as an individual in question may have crossed the state borderto be tested. Such is the case of Pleasants and Putnamcounties in this report.

Please visit the dashboard at http://www.coronavirus.wv.gov for more detailed information.

Additional report:

Toincrease COVID-19 testing opportunities, the Governor's Office, the HerbertHenderson Office of Minority Affairs, WV Department of Health and HumanResources, WV National Guard, local health departments,and community partners today provided freeCOVID-19 testing for residents in counties with high minority populations andevidence of COVID-19 transmission.

Todays testing resulted in 2,589 individuals tested: 323in Marshall County; 1,368 in Monongalia County; 407 in Preston County; 51 inWayne County; and 440 in Upshur County. Please note these are consideredpreliminary numbers.

Testingin the same counties will continue tomorrow in these locations.

See the original post:

COVID-19 Daily Update 7-10-2020 - 5 PM - West Virginia Department of Health and Human Resources

Hundreds of Pa. nursing homes haven’t finished COVID-19 testing; local lab hired to help – LancasterOnline

A Lancaster County lab is helping test nursing home residents and staff for COVID-19, the Pennsylvania Department of Health said this week.

The department saidLancaster Laboratories Eurofins in Leola is being used as an overflow lab to assist the state's laboratory with testing it's requiring nursing homes to finish by July 24. It announced a similar partnership with Omnicare, a CVS Health company, about two weeks ago.

More than 300 of the state's 695 licensed nursing homes have completed the required testing, spokeswoman Maggi Mumma said in an email.

Lancaster Laboratories provides analytical testing services to the bio/pharmaceutical, food, environmental and medical device industries and is among the county's largest employers. It's owned by Eurofins Scientific, a Luxembourg-based firm that employs 25,000 people across 39 countries.

Pennsylvania has averaged 16,876 tests daily for the last two weeks, and the the state's lab can handle about 1,200 tests a day with 24-hour turnaround for results, according to the department.

The department did not say how much it's paying Eurofins per test, but noted that it has budgeted for roughly 40,750 tests, and the cost is being covered by a federal grant.

"Increased testing, especially in long-term care facilities, will help us determine the number of our most vulnerable Pennsylvanians who have been infected by COVID-19," Mumma wrote in an email. "Each individual who tests positive is followed through a case investigation and contact tracing."

Success! An email has been sent with a link to confirm list signup.

Error! There was an error processing your request.

As of Wednesday, the Lancaster County coroner's office said 301 of the 359 local deaths caused by COVID-19 were residents of nursing or personal care homes.

The state's most recent report shows 1,128 cases among residents and 313 among staffers at 45 of the county's nursing and personal care homes.

Statewide, the figure is 18,092 resident and 3,396 staffer cases at 732 facilities. On June 1, those figures stood at 15,545 resident and 2,663 staff cases at 608 facilities.

Subscribe today for only $2

' + submsgtxthtml + '

Get unlimited access to breaking news, ancestry archives, our daily E-newspaper, games and more.

Subscribe today for only $2

' + submsgtxthtml + '

Get unlimited access to breaking news, ancestry archives, our daily E-newspaper, games and more.

Subscribe today for only $2

' + submsgtxthtml + '

Get unlimited access to breaking news, ancestry archives, our daily E-newspaper, games and more.

Subscribe today for only $2

' + submsgtxthtml + '

Follow this link:

Hundreds of Pa. nursing homes haven't finished COVID-19 testing; local lab hired to help - LancasterOnline

Public Health Reports 2 More COVID-19 Deaths, Says Many Recent Cases Linked to Gatherings, Parties – Noozhawk

Two more COVID-19-related deaths were reported Friday in Santa Barbara County after what Supervisor Gregg Hart called another very difficult week.

At the latest briefing, public health officials said the county has 75 COVID-19-related hospitalizations, including 23 people in intensive care units, which is a 25 percent increase in the past week.

Positive COVID-19 cases are rising significantly across all parts of Santa Barbara County, California and the nation, Hart said.

Because of the increase in local COVID-19 patients, Santa Barbara Cottage Hospital decided to reduce the number of elective procedures by half starting Monday.

This will ensure that we can provide lifesaving care for the predicted surge of COVID-positive cases while still safely caring for patients who require emergency and essential care for non-COVID conditions, Ron Werft, president and CEO of Cottage Health, said in a statement Friday.

Local hospitals previously postponed elective procedures and surgeries from mid-March until May.

Intensive care units across the county are collectively 56 percent full, including COVID-19 and non-COVID-19 patients, Public Health Director Van Do-Reynoso said. That is concerning because hospitalized COVID-19 patients can require intensive care with little warning, she said.

The two deaths reported Friday were Santa Maria residents in their 70s who lived in skilled nursing facilities experiencing outbreaks, she said. At least one of the people lived in the Country Oaks Care Center, where 10 other residents have died in the COVID-19 outbreak.

Do-Reynoso reported 75 more COVID-19 cases on Friday, and said that contact tracing investigations have linked recent cases, since July 1, to close contact exposures at family gatherings, Father's Day gatherings, Fourth of July parties, funeral services, church services, jail and bars.

You must assume that everyone you come into contact with may be infectious, she said.

Do-Reynoso urged everyone to not become complacent, telling people to keep social distancing, wearing face coverings, disinfecting surfaces and washing hands frequently.

Im taking this seriously and paying special attention to the details again because it's our best, and frankly, only defense, Hart said.

Nick Clay, director of the County Emergency Medical Services Agency, said the large demand for COVID-19 testing at the state-run community testing sites means the facilities are being booked to capacity. There has been a trend of missed appointments, and he asked people to cancel their appointments if they cannot make it, so someone else can get the testing slot.

Santa Barbara County is now asking community members to request a test through these state-run facilities only if they have symptoms or an exposure to someone who tested positive for COVID-19.

We adjusted our messaging several weeks ago from a want to get tested to a need to get tested message, Clay said.

Labs are overwhelmed with the increased demand for testing, and test results are taking up to a week, according to the Public Health Department.

The number of tests administered in the county has more than doubled from what it was a month ago, said Dr. Stewart Comer, who heads the county's public health laboratory. The county had conducted 54,000 tests as of Friday, he said.

Hart said the county will continue to use an educational approach to get compliance with public health orders, including the face coverings mandate.

Although he said that ticketing individual citizens who do not wear face coverings would be too hard to enforce, public health officials will continue to message, explain and urge residents to wear masks to "take care of all of us together."

He also said the county is developing cease-and-desist letters as a way to address noncompliance by businesses who are repeat offendersviolating public health orders.

We are not ultimately going to enforce our way out of this problem. Were going to encourage people to do the right thing,Hart said.I strongly believe were all going to get through this together by modeling proper behavior and setting the best possible example. We will be facing this pandemic for a longer period of time than we all initially hoped. This is not a sprint, it's a marathon, and perhaps even an ultra-marathon.

Noozhawk staff writer Jade Martinez-Pogue can be reached at .(JavaScript must be enabled to view this email address). Follow Noozhawk on Twitter: @noozhawk, @NoozhawkNews and @NoozhawkBiz. Connect with Noozhawk on Facebook.

See the rest here:

Public Health Reports 2 More COVID-19 Deaths, Says Many Recent Cases Linked to Gatherings, Parties - Noozhawk

Why We Still Dont Know Enough About Covid-19 and Pregnancy – The New York Times

Unlike the data from the C.D.C., pregnancy is the primary inclusion criteria, said Dr. Afshar, who is a co-principal investigator of the U.C.S.F. and U.C.L.A. study.

Women can register for the study themselves, regardless of where they are getting care, rather than relying on a clinician referral, she added. So far, more than 950 women have enrolled from across the country, and about 60 percent of them have Covid-19.

U.C.S.F. has also started another large, national study for pregnant women in their first trimester called ASPIRE that will follow about 10,000 women and their babies from the start of pregnancy through delivery and up to 18 months postpartum.

This data is vital given that there are gaping holes in the health information used by the C.D.C.

In the C.D.C. study, the researchers found that pregnant women with Covid-19 were more likely to be hospitalized than nonpregnant women who had the virus, but it did not say whether the pregnant women were hospitalized because of labor and delivery, or because of complications from Covid-19. Data sets that the researchers would have needed to make that distinction were not available, the study said.

The data on whether or not infected pregnant women were admitted to the I.C.U. or whether they required mechanical ventilation was missing for about 75 percent of the patients. Using the data that was available, the researchers determined that pregnant women with Covid-19 were more likely to be admitted to the I.C.U. than nonpregnant women (the numbers appeared to be slightly more than the percentage of pregnant women admitted in the past, when compared to data from a 2010 study). Similarly, the study found pregnant women with Covid-19 were more likely to end up on mechanical ventilators than infected nonpregnant women, though the differences were quite small.

Its really hard scientifically to know what that means unless you have an appropriate control group, Dr. Huddleston, one of the principal investigators of the ASPIRE study, said. In other words, researchers also need a control group of pregnant women who are not infected.

Despite the caveats of the C.D.C. study, it remains a signal that pregnant women could be more susceptible to severe Covid-19 symptoms, Dr. Bryant said, adding, its not super surprising given what we know about other respiratory illnesses like flu.

Continued here:

Why We Still Dont Know Enough About Covid-19 and Pregnancy - The New York Times

Some positive COVID-19 cases in Tompkins Co. have been linked to Fourth of July gatherings – WETM – MyTwinTiers.com

ITHACA, N.Y. (WSYR-TV) The Tompkins County Health Department announced that there have been positive COVID-19 cases related to some Fourth of July gatherings.

The cases are connected to out-of-state travel to states with significant increases in cases. Some of those cases are connected to local, social gatherings where social distancing was not practiced and masks were not worn.

We have come a long way, but we are not done with COVID-19. I strongly remind all residents to remain vigilant and take all precautions to prevent the spread of COVID-19. People traveling are still bringing the disease into our community, increasing the potential of spread. The Health Department is discouraging all non-essential travel to affected states. Masks are required in public spaces, especially indoors, where distance cannot be maintained. Masks and face-coverings are a simple measure we can all take to prevent exposing others to the virus.

If someone is infected when people come together for a social gathering and do not observe the recommendations for distancing and mask-wearing, everyone is exposed, said Frank Kruppa, the Tompkins County public health director.

If you travel to a state on the travel advisory list sent out by New York State, you are required to quarantine for 14 days once you return.

Completing the full 14 days of quarantine is critical to keeping the disease from spreading. Getting tested does not replace the full quarantine because a test is only one moment in time; you could test negative one day and positive a few days later as the disease incubates or you are exposed to a new source of COVID-19. We all have to stay vigilant.

Anyone who is experiencing symptoms or is concerned about being exposed should get tested.

You can get tested at the Cayuga Health Sampling Site Monday through Friday from 8:30 a.m. to 4 p.m.

To pre-register for an appointment, call (607) 319-5708 orclick here.

Everyone can take the following steps to help stop the spread of coronavirus:

If you would like to file a complaint about a business or social gathering, click here.

Read more:

Some positive COVID-19 cases in Tompkins Co. have been linked to Fourth of July gatherings - WETM - MyTwinTiers.com

With 46 new COVID-19 cases Friday, Spokane is ‘back to where we were in March’ – The Spokesman-Review

Spokane County health officials announced 46 new cases of COVID-19 on Friday, bringing the weekly county total to 373 and the countys overall tally to 1,942.

Hospitalizations of county residents, which were predicted in mid-June to double, have done so.

About a dozen county residents were hospitalized in mid-June, and 27 residents were as of Friday. But Spokane hospitals are also treating another 15 COVID-19 patients total, including residents from outside the county.

With ballooning case counts, community spread and backlogged test results, Spokane County Health Officer Dr. Bob Lutz said the county is, in essence, truly back to where we were in March.

The health district continues to identify cases tied to local businesses as well as cases not connected to any other confirmed cases, which is a sign of community spread.

Lutz expressed concerns about residents not adhering to Phase 2 guidelines for gatherings, which should involve fewer than five people, with face coverings and physical distancing in place.

Processing of tests is backed up at national laboratories, causing wait times of up to a week for people awaiting test results. But Lutz reiterated that people waiting for test results must isolate at home until they get them back.

The presumptive diagnosis is that youre positive. Even if your symptoms lessen, you need to keep self-isolating, he said.

With case counts increasing in the Panhandle Health District of North Idaho and in some Eastern Washingtons rural counties, Lutz said he is concerned about the region in general.

The Northeast Tri County Health District confirmed seven new cases across all three counties in one day this week, which was a record.

Matt Schanz, administrator of the health district in the counties, said the increase is concerning because some of these cases were acquired locally, meaning the virus has spread within the three counties, even as some cases were acquired by traveling outside the tri-county region.

We know theres person-to-person transmission in our counties, Schanz said.

What is happening in Spokane County will impact what happens in nearby counties, Schanz said, especially when it comes to hospital capacity.

We are joined at the hip to Spokanes medical system through Providence and MultiCare, Schanz said, noting that patients who need intensive treatment for the virus in intensive care units will likely receive that care in the Lilac City.

A stressed Spokane hospital system would impact their ability to move ahead in the governors reopening phases, although all counties are frozen at the moment and not allowed to apply to advance further due to case counts increasing statewide.

The Northeast Tri County Health District announced that an employee of the Colville McDonalds tested positive for the virus on Thursday, and the restaurant closed for a deep cleaning. Employees identified as close contacts have been asked to complete a two-week quarantine before returning to work, and no customers were identified as close contacts.

More:

With 46 new COVID-19 cases Friday, Spokane is 'back to where we were in March' - The Spokesman-Review

Covid-19 has revealed a pre-existing pandemic of poverty that benefits the rich – The Guardian

Poverty is suddenly all over the front page. As coronavirus ravages the globe, its wholly disproportionate impact on poor people and marginalised communities is inescapable. Hundreds of millions of people are being pushed into poverty and unemployment, with woeful support in most places, alongside a huge expansion in hunger, homelessness, and dangerous work.

How could the poverty narrative have turned on a dime? Until just a few months ago, many were celebrating the imminent end of poverty; now its everywhere. The explanation is simple. Over the past decade, world leaders, philanthropists and pundits have embraced a deceptively optimistic narrative about the worlds progress against poverty. It has been lauded as one of the greatest human achievements, a feat seen never before in human history and an unprecedented accomplishment. But the success story was always highly misleading.

As I show in my final report as UN special rapporteur on extreme poverty and human rights, almost all of these rosy accounts rely on one measure the World Banks $1.90 (1.50) a day international poverty line which is widely misunderstood, flawed and yields a deceptively positive picture. It has generated an undue sense of satisfaction and a dangerous complacency with the status quo.

Under that line, the number of people in extreme poverty fell from 1.9 billion in 1990 to 736 million in 2015. But the dramatic drop is only possible with a scandalously unambitious benchmark, which aims to ensure a mere miserable subsistence. The best evidence shows it doesnt even cover the cost of food or housing in many countries. And it obscures poverty among women and those often excluded from official surveys, such as migrant workers and refugees. Much of the touted decline is due to rising incomes in a single country, China.

The consequences of this highly unrealistic picture of progress against poverty have been devastating.

First, it is attributed to economic growth, justifying a pro-growth agenda characterised by deregulation, privatisation, lower taxes for corporations and the wealthy, easy movement of money across borders and excessive legal protections for capital. In my six years investigating governments anti-poverty efforts for the UN, I encountered this convenient alibi time and time again. Everything from tax breaks for the super-rich to destructive mega-projects that extract wealth from the global south are lauded as efforts to reduce poverty, when they do no such thing.

Presenting the agenda of the wealthy as the best road to poverty alleviation has entirely upended the social contract and redefined the public good as helping the rich get richer.

Second, the progress narrative has been used to drown out the appalling results so often brought about by this perversion of pro-growth policies. Many of the countries that have achieved great growth in GDP have also experienced exploding inequality, rising hunger, unaffordable health and housing costs, persistent racial wealth gaps, the proliferation of jobs that dont pay a living wage, the dismantling of social safety nets and ecological devastation. These phenomena, directly related to neoliberal policies, are unaccounted for in the tale of heroic gains against poverty.

Third, the rosy picture painted by the World Banks most publicised poverty measure has encouraged complacency. Billions of people face few opportunities, preventable death and remain too poor to enjoy basic human rights. About half the world, 3.4 billion people, lives on less than $5.50 a day, and that number has barely declined since 1990. Even high-income countries with ample resources have failed to seriously reduce poverty rates.

The coronavirus has merely lifted the lid off the pre-existing pandemic of poverty. Covid-19 arrived in a world where poverty, extreme inequality and disregard for human life are thriving, and in which legal and economic policies are designed to create and sustain wealth for the powerful, but not end poverty. This is the political choice that has been made.

Nowhere are these problems more evident than the UNs sustainable development goals, which are clearly not going to be met without drastic recalibration. The SDG framework places immense and mistaken faith in growth and the private sector, rather than envisioning states as the key agents of change and embracing policies that will redistribute wealth and address precarity.

Until governments take seriously the human right to an adequate standard of living, the poverty pandemic will long outlive coronavirus. This requires them to stop hiding behind the World Banks miserable subsistence line and abandon triumphalism about the imminent end of poverty. Deeper social and economic transformation is imperative, to avert a climate catastrophe, provide universal social protection, achieve redistribution through tax justice and ultimately to really get on track to ending poverty.

Philip Alston is John Norton Pomeroy professor of law at New York University School of Law and co-chair of the Center for Human Rights and Global Justice. He was the UN special rapporteur on extreme poverty and human rights from 2014-2020

Read the original:

Covid-19 has revealed a pre-existing pandemic of poverty that benefits the rich - The Guardian

Kingston health-food store worker tests positive for Covid-19: Shoppers urged to get tested – Hudson Valley One

Ulster County Commissioner of Health Dr. Carol Smith announced today that an employee at Mother Earths Storehouse in Kingston has tested positive this week for COVID-19. Anyone who has shopped at this Mother Earth store from July 1st to July 5 is urged to promptly contact their primary care physician and seek testing, or contact the Ulster County COVID-19 hotline at (845) 443-8888.

I urge anyone who has recently shopped at Mother Earth in Kingston to be alert and monitor their symptoms, said Smith. We are encouraging residents, who may have been in the Kingston Mother Earth store from July 1st through July 5th, to be tested for COVID-19 at one of the Countys many walk-in or mobile testing sites. We will continue to monitor the situation and take measures to minimize the spread of this disease including completing contact tracing to inform those who may have been in contact with this individual. As we see cases continue to rise across the country, we must continue to follow critical safety precautions including wearing masks, social distancing, and washing our hands to protect the health and safety of our community.

The Ulster County Department of Health has recommended the store is thoroughly cleaned and disinfected and is working with the New York State Department of Health to ensure they are following proper protocols.

Residents can find information about their nearest testing location and both walk-in testing sites and mobile testing sites by visitingulstercountyny.gov/get-tested.

There are currently 134 active cases of COVID-19 in Ulster County and 88 fatalities.

Read more from the original source:

Kingston health-food store worker tests positive for Covid-19: Shoppers urged to get tested - Hudson Valley One

Medical care for very ill COVID-19 patients is getting better – USA TODAY

The U.S. is currently facing a shortage of ventilators. Here's how they work and why they are so important in fighting COVID-19. USA TODAY

When Dr. Carl June first heard about symptoms in seriously ill COVID-19 patients, his thoughts jumped to Emily Whitehead.Emily, 7, had endured the same kind of immune systemoverreaction when June treated her in 2012 with an experimental therapy against her leukemia.

Her immune system went into life-threatening overdrive, just like many of those with COVID-19.

In a last-ditch effort to save Emily's life, he had given her a drug,tocilizumab, that kept his own daughter's rheumatoid arthritis under control. To everyone's surprise, the drug worked. Emily is now a normal teenager.

Tocilizumab is one of hundreds of therapies being tested against COVID-19.

Four months ago when COVID-19 arrived in the USA, there were no therapies shown to treat it. Doctors relied solely on what's called supportive care, including intravenous fluids, fever reducersand ventilators, the bulky machines that allow people to breathe when they can't do it on their own.

There are two approved therapies shown to make a difference in COVID-19, and 150 treatments and more than 50 antivirals are being tested in people.

A treatment that kept people from falling seriously ill or even needing hospitalization could strip the fear from the coronavirus andallow people to resume their pre-COVID-19 lives.

Once somebody develops a treatment for the virus, everything will go away, said Daniel Batlle, a kidney expert from Northwestern Medicine and professor of medicine at Northwestern University in Chicago.

Even after a vaccine is developed, treatments that save lives and prevent hospitalization will be crucial.Vaccines might not work for everyone, and doses may initially be limited.

The majority of people diagnosed with COVID-19 more than 80% will recover without the need for hospitalization or significant treatment.

For those who do require care, treatments haveevolved as researchers learn more about the coronavirus and the infection it causes, as well as the damage it can do tovarious parts of the body.

Potential therapies being tested, experts said, fall into four major categories that are best used at different times:

Even as these different approaches are tested, many unanswered questions and challenges remain. One is how to treat patients who might have different responses to the virus, said Dr. John Wherry, director of the institute for immunology at the Perlman School of Medicine at the University of Pennsylvania.

At Penn, he and his colleagues have seen three types of patients: a large group whose immune system is overreacting, a small group whose immune system is underreacting, and others whose immune system is more balanced in the response.

Drugs are tested on all patients without making any distinction, Wherry said. That means ones that tamp down the immune system might help patients with an overactive immune systembut hurt those whose immune systems arent working hard enough, and do nothing for those with a balanced immune response.

Drugs that might be useful for patients with too little immune response might be seen as ineffectivebecause they don't help the larger number of people with immune overreactions, he said.

Wherry said researchers are getting closer to identifying which patients are likely to do better with which kind of therapy. We still need to be pushing very hard and thinking very creatively about how to match treatments to the right patient, he said.

Doctors learn other approaches simply by treating patients.

Batlle, the kidney expert, said that although COVID-19 has been considered a lung disease, as many as half of patients hospitalized with severe cases also suffer acute kidney injury. Its notclear how many patients will be left with long-term kidney problems after recovering from severe cases of COVID-19.

We dont want to scare anybody, but kidney damage was initially underreported, and now several studies have shown that it is extremely frequent in hospitalized patients," he said.

Treatment for acute kidney injury usually involves dialysis, which removes toxins from the blood that the kidneys can no longer address. Batlle hopes treatments that address COVID-19-related inflammation and formation of blood clots will eventually reduce such injuries.

We should be better prepared to help these patients and not rely (only)on supportive care, he said.

As coronavirus cases in some states start to rise again, make sure to remember these safety tips. USA TODAY

Since mid-May, dexamethasone and remdesivir have been shown useful for certain COVID-19 patients. Both are recommended by the National Institutes of Health and the Infectious Disease Society of America.

For hospitalized patients, these drugs are beginning to show an effect, said Dr. Rajesh Gandhi, an infectious disease specialist at Massachusetts General Hospital who sits on both panels.

Placing patients on their stomachs rather than their back when they have breathing problems may help, according to some experts.

Gandhi and other doctors said they are much more comfortable treating COVID-19s many symptoms, which can include blood clots, immune problems and organ failure, in addition to lung issues.

Get daily coronavirus updates in your inbox:Sign up for our newsletter

Some said COVID-19 is a multi-system disease, targeting at times the lining of blood vessels. This would explain how it damages so many of the body's organs, all of which are fed by blood vessels.

A study by theRecovery Collaborative Group, still not fully vetted, showed that dexamethasone, at a dose of 6 mg per day for up to 10 days, can be lifesaving for patients with COVID-19 who are on ventilators. The evidence was weaker for patients who are hospitalized and receiving oxygen. The study found no support for giving the steroid to less seriously ill COVID-19 patients, but more research is underway.

According to a study in May in the New England Journal of Medicine,the drug remdesivir, developed to treat Ebola, shortened the recovery time of patients hospitalized with COVID-19 and lower respiratory tract infections.

Scientists said remdesivir might be even more effective in people who are notsick enough to require hospitalization, but because it can be delivered only intravenously, it has not been tested on outpatients. Its manufacturer, Gilead, is rushing to ramp up production and to develop an inhaled version of the drug.

Although remdesivir is helpful, it doesnt cure COVID-19 and is far from a home run, said Dr. Mark Rupp, an infectious disease expert at the University of Nebraska.

Its kind of like getting on base with a single, he said. Weve got a long way to go.

Although its tempting tothrow everything in the medicine cabinet at COVID-19, Rupp said he learned while fighting Ebola in 2014-2015 that its much more important to conduct high-quality clinical research during an outbreak.

Without such research, you throw the kitchen sink at everybody, and you dont know what helps and what hurts and thats a dangerous place to be, he said.

He cited the example of hydroxychloroquine,which was used early on to treat COVID-19 before research showed it was ineffective in very sick patients.

Everybody wants to do good, we want to help our patients, Rupp said. But sometimes well-meaning efforts really dont result in beneficial effects.

Its only by testing drugs and other therapies through clinical trials that doctors learn what works and what doesnt, he said. The more data and information we can gather, the better off were going to be.

Autoplay

Show Thumbnails

Show Captions

Health and patient safety coverage at USA TODAY is made possible in part by a grant from the Masimo Foundation for Ethics, Innovation and Competition in Healthcare. The Masimo Foundation does not provide editorial input.

Read or Share this story: https://www.usatoday.com/story/news/health/2020/07/09/how-treat-covid-19-tocilizumab-other-drugs-being-tested/5383726002/

See original here:

Medical care for very ill COVID-19 patients is getting better - USA TODAY

How Scientists Got Coronavirus While Trying to Find a Drug for the Disease – The New York Times

In January, as a frightening new virus filled hospital wards in Wuhan, China, Stephanie Giordano, a 25-year-old researcher at the drugmaker Regeneron, in a suburb of New York City, began working on a treatment for the disease.

By March, the deadly coronavirus had hit home. Fearing she would get infected on the train that took her to the lab every day, she moved from her apartment in East Harlem to an Airbnb five minutes from the companys headquarters in Tarrytown, in Westchester County.

Then her mother, a nurses assistant who cared for newborn babies at a Long Island hospital, was reassigned to a Covid-19 ward where she tended to older people struggling to breathe. No drug could help these patients or her, if she were to get sick, too.

I had somebody on the line that I really cared about, Ms. Giordano said recently. And I wanted to see her make it through this.

Ms. Giordano, the youngest member of the companys five-person rapid response team for infectious diseases, helped develop what many consider one of the most promising new treatments for Covid-19, which has now infected more than 12 million people around the world, and killed more than 549,000.

She worked in the lab until 10 many nights and through weekends, screening thousands of antibodies the weapons of the immune system that seek out and destroy viruses in search of the most powerful ones. The result was a cocktail of two antibodies that might not only treat the virus, but prevent it by giving the body the same natural defenses that people infected with it produce on their own.

The Trump administration this week gave a major boost to Regenerons treatment, awarding the company $450 million to manufacture and supply as many as 300,000 doses as treatments or 1.3 million doses to prevent infection. Thats in addition to $160 million in federal money the company had already received to run clinical trials and ramp up manufacturing. After the treatment passed an initial safety study, Regenerons broader trials to evaluate the products efficacy got underway.

Dr. Francis S. Collins, the director of the National Institutes of Health, recently singled out the treatment as the most likely to pan out soon. If I had to pick one, I think the monoclonal antibody cocktails have a lot going for them, Dr. Collins said at a Senate hearing last week. Theres all kinds of reasons to think this is the kind of virus it should work for.

If the trials are successful, company executives have said the treatment could be available by the end of the summer. The hope is that it could serve as a stopgap until a vaccine arrives by providing temporary protection to people at high risk of getting infected.

Regeneron is making a significant gamble, ramping up manufacturing of the antibody cocktail before clinical trials have even proved that it works. The most lucrative drugs it makes for other diseases have been relocated to a factory in Ireland.

Regeneron is one of several companies pursuing monoclonal antibody treatments. The drug giant Eli Lilly has also begun clinical trials, and others working on antibody treatments include partnerships of Amgen and Adaptive Biotechnologies and also Vir Biotechnology and GlaxoSmithKline.

Its unclear which of these projects if any will succeed. Drug development is notoriously unpredictable: Just last week, Regeneron announced that an older monoclonal antibody drug, the rheumatoid arthritis treatment Kevzara, had failed to help patients critically ill with Covid-19.

Still, scientists and investors alike are closely watching Regeneron, which developed a treatment for Ebola with this same technology. That treatment was tested during the most recent Ebola outbreak in the Democratic Republic of Congo, which began in 2018 and ended in June. Together with a new Ebola vaccine, the treatment was credited with reducing the deadliness of the outbreak.

Regenerons track record of developing a similar treatment for Ebola doesnt mean they will have a better product, but it does make me relieved that they will not fumble, said Ronny Gal, an analyst for Bernstein, a Wall Street firm.

And Regeneron has taken this all-hands-on-deck approach to Covid-19 in one of the hardest-hit areas of the country. In Westchester County, more than 35,000 people have been infected and more than 1,500 people have died.

Its just a remarkable and unfortunate coincidence, said Dr. Leonard S. Schleifer, Regenerons chief executive.

Ms. Giordano, a research and development associate with a bachelors degree in chemistry from Fordham University, had just transferred to Regenerons viral infectious disease group in January when the researchers noticed a report about a new virus in Wuhan on an international alert system known as ProMED.

Christos Kyratsous, the companys vice president of research for infectious diseases, said his team ordered a synthetic genome of the virus from an outside company, but while they waited for it to arrive, the number of infections simply exploded. While Dr. Kyratsouss team closely watches any new viruses, the way it spread across Wuhan convinced us that this was something worth spending our resources and our time on.

Regeneron has built its business on what Dr. Schleifer, one of the companys founders, calls its magical mice animals that have been genetically engineered to have human immune systems. The mice are infected with harmless viruses that trigger the animals to produce human antibodies. Those antibodies can then be screened for the ones that work best, and then mass-produced in stainless steel vats known as bioreactors.

The technology drove one of the companys biggest blockbusters, the eczema drug Dupixent, as well as the treatment for Ebola.

Dr. Schleifer said he realized the company would need to turn its full attention to developing a treatment in late January, when a news program showed construction vehicles breaking ground on a vast hospital in Wuhan.

They said they were going to build a hospital in five days, he recalled. I said to myself, Holy cow, OK, this doesnt happen just for the fun of it.

In early February, Regeneron expanded a collaboration with the federal government to begin working on the coronavirus treatment. It also started ramping up manufacturing of the antibodies.

Usually, you dont scale it up until youve got something thats proven, Dr. Schleifer said. We knew that the ordinary course of business could not work here. We knew that we needed to get as much capacity as possible.

Dr. Schleifer said the company decided to move its existing products to its plant in Ireland to ensure that the antibody treatment would be made in the United States and available to treat Americans. The pandemic has already led some countries, such as India, to limit exports of drugs that might treat Covid-19, and the United States has snapped up the global supply of another treatment, remdesivir.

There was scary stuff going on in the world about, you know, countries closing borders, he said. We wanted to manufacture as much as we could as close to where the processes were being developed.

The company started its work by collecting as many coronavirus antibodies as possible, both through infecting its magic mice, and from the donated blood of coronavirus survivors.

Those antibodies were handed off to Ms. Giordanos team, which identified the ones that fought off the virus most powerfully.

Ms. Giordanos role was to help develop a phony coronavirus to test against the companys antibody candidates one that, though not harmful, would stand in for the real thing. It was like three years of work in I want to say maybe like a month and a half, she said.

By the end of February, she was clocking 90 hours a week. In March, as the coronavirus arrived in Westchester, she moved to the Airbnb apartment in White Plains the owners gave her a significant discount when she explained what she was working on.

As her mother began caring for Covid-19 patients, the two exchanged photos of each other in their protective gear.

You guys are heros!!!!!!! Ms. Giordano texted in April to her mother, who had sent photos of herself and her co-workers in protective gowns, gloves, face shields and masks. Love ur double glove technique.

Ms. Giordano said that thinking about her mother and her colleagues being at risk of infection kept her going during the grueling days. Because otherwise I think I would have broken down and cried a lot.

As the cases in Westchester County mounted and the state locked down, officials at Regeneron scrambled to keep their labs open without putting employees in danger.

We were truly petrified that we would have this cure that we knew we had to develop, but all of our scientists would get sick and we wouldnt be able to do it, Dr. Schleifer said.

Like many other businesses, the company sent nonessential workers home including Dr. Schleifer, who did conference calls and television appearances from a bedroom in his home. They redirected some cars used by sales representatives to workers who would otherwise rely on public transportation. They staggered researchers shifts so fewer people were in the labs at once.

In late April, the company set up a drive-through testing site in its parking lot, and now requires all employees to get tested at least once every two weeks.

Ms. Giordano and her colleagues, working long hours, took turns grocery shopping at Whole Foods, taking orders for the group. She recalled getting home late one night, eating a bag of defrosted broccoli and carrots for dinner, then collapsing.

In April, the scientists selected their lead candidates for the two-antibody cocktail that would eventually enter clinical trials.

Ms. Giordano turned 25. The group celebrated with a chocolate cake covered in sprinkles. She cut her own bangs. She downloaded the new album by the Strokes, and played it on tiny speakers next to her lab station. (Lana Del Rey was in heavier rotation earlier in the pandemic, she said, because I needed something melodramatic and just kind of soothing in the background.)

Ms. Giordano was listed as an author on two articles in the journal Science describing how Regenerons researchers had selected the antibody cocktail, including their reasoning that, by using two antibodies, they could help prevent resistance to the treatment.

So proud of you!!! her mother wrote in a text.

Now, like everyone else, Ms. Giordano is waiting to see if the antibody treatment will succeed in clinical trials.

While antibody treatments have shown promise in the past, the real question is how well will they work for Covid? said Angela Rasmussen, a virologist at Columbia University. And thats something thats really hard to say, because weve only known about this virus for seven months.

The clinical trials will test how well the antibodies work for three groups: people who are hospitalized, those who are mildly ill and those who have been exposed to someone with the virus. The product will be given as an infusion for people who are sick, and as a lower-dose injection when it is used for prevention. The preliminary results are expected by late summer.

The most intense phase of Ms. Giordanos work on the treatment is now over, and her work schedule has mainly returned to normal. She moved to a new apartment in Greenpoint, Brooklyn, and, as the outbreak ebbed in New York, her mother went back to caring for babies.

She knows the treatment may not ultimately work. Its so scary, she said. But she tries to focus on the science, not her fears.

We did our best, and we tried everything that we could to make something that works, she said. And I think thats enough for now.

See original here:

How Scientists Got Coronavirus While Trying to Find a Drug for the Disease - The New York Times

Doctors are better at treating COVID-19 patients now than they were in March – The Verge

In early March, most doctors in the United States had never seen a person sick with COVID-19. Four months later, nearly every emergency room and intensive care physician in the country is intimately familiar with the disease. In that time, theyve learned a lot about how best to treat patients. But in some cases, theyre still taking the same approach they did in the spring.

Theres so much thats different, and so much thats the same, says Megan Ranney, an emergency physician and associate professor at the Brown University Department of Emergency Medicine.

For the first few months of the pandemic, recommendations for every incremental decision made in a hospital were changing faster than they ever have before. You almost couldnt keep up from one day to the next, your practice would change and your protocols would change. It was really disorienting for doctors and nurses, Ranney says.

Information spread between colleagues, through medical education blogs and podcasts, and on social media. Doctors talked about new research on Twitter and shared new strategies in Facebook groups and on WhatsApp. If a suggestion that floated by a doctor in a Facebook group was low-risk and seemed like it might be helpful, it could be put into practice immediately. If its a small change, they could start using it the next day, she says.

Thats how the now-common practice of asking patients with COVID-19 to flip onto their stomachs spread: through word-of-mouth and on social media. When someone is on their back, their organs squish their lungs and make it harder for their airways to fully expand. When someone is on their stomach, their lungs have more room to fill up with air. The advice started circulating through the medical community before there was a formal, published study on the practice.

Testing it out wouldnt have many downsides (it wasnt dangerous to patients), and it was easy to do. Theres this possibility that it could be positive, and there were a lot of stories about it having a positive effect, Ranney says. So, it spread in a much more organic and quick way, because it was something that we could do, but we werent worried it would hurt patients.

Doctors like Seth Trueger, an assistant professor of emergency medicine at Northwestern University, saw the position help patients get enough oxygen to avoid needing a ventilator. I started jokingly call it tummy time, he says. Studies are starting to validate those observations, finding that patients who spent time on their stomachs were, in fact, better off.

Since March, physicians have also figured out other ways to help severely ill patients avoid ventilation. We appreciate that its probably not a great thing for these patients, and weve developed other ways to get people high levels of oxygen, says James Hudspeth, the COVID response inpatient floor lead at Boston Medical Center. For example, doctors are turning to nasal cannulas, which are noninvasive prongs that blow oxygen into the nose, before a ventilator.

They have better medications for hospitalized patients now, too. Since March, doctors have cycled through a few different options like hydroxychloroquine, which turned out not to be effective. Now, theyre primarily using remdesivir, an antiviral drug that appears to help COVID-19 patients recover more quickly, and the steroid dexamethasone, which helps improve the survival rate for patients on ventilators. Many intensive care units and many hospitals have created their own standard order sets, or standard therapies, for people with COVID-19, Ranney says. Those shift as new evidence comes out around different medications.

Thats not unusual, Ranney says. Hospitals regularly change the drugs they use for conditions like flu and pneumonia as new data comes out. Whats unusual is to change practice so quickly, she says. Thats just the reality of a global pandemic, with a disease weve never seen before.

Most of the changes in doctors strategies over the past few months have been in patients who are severely ill. If someone is sick enough to be hospitalized with COVID-19 but doesnt need to be in intensive care, there still isnt much doctors can do for them. Theyll get fluids to make sure they stay hydrated and are given oxygen if they need it. Doctors will try to keep their fever down and monitor them to see if they get sicker, but thats about it.

Its just those basic things, Ranney says. Doctors now are more vigilant to the threat from blood clots, which have appeared in many COVID-19 patients over the past months. Because testing is more available in hospitals than it was earlier this year, theyll also confirm that a moderately ill patient actually does have COVID-19 and avoid giving them unnecessary treatments. But active interventions for patients with less severe symptoms are still around the same as they were back in March. Were still kind of in this watchful waiting, she says.

One lingering question, Hudspeth says, is figuring out how to keep those moderately ill patients from becoming severely ill. Steroids may be helpful earlier on, he says, as could artificial antibody treatments that block the virus, though those strategies are still under investigation. Part of the challenge we face at the present moment is that the moderate patients are often where we would want to intervene, he says.

Changes to treatment strategies for patients who are not severely sick have been harder to come by in part because its riskier to try something new in that group. If someone isnt dangerously sick, there isnt as much to gain from using an experimental treatment that may have a chance of causing harm, so doctors are less likely to take risks. Were more likely to try stuff with sicker patients, Ranney says. And their families are more likely to consent to a clinical trial.

Despite the open issues around COVID-19 treatments, the rate of new information is slowing down. Doctors arent shifting their practices as quickly as they were back in March and April, and Trueger says he thinks the next few months may be relatively stable. Doctors might get new information about which medications are more or less helpful, but other common best practices might be more entrenched. I dont think things are going to change as rapidly as the changes we had up front, when we were really flying half blind, he says.

See the rest here:

Doctors are better at treating COVID-19 patients now than they were in March - The Verge